Nav: Home

Atomic-scale simulation of antiarrhythmic drug interaction with cardiac cells

February 06, 2019

To unravel the mysterious mechanisms of drug potency for the treatment of cardiac arrhythmias, a group of researchers at UC Davis have developed novel simulations that provide insights on vital atomic-scale drug-cardiac cells interactions.

These simulations, published today in PNAS (Proceedings of the National Academy of Sciences), may lead the way to better development of new antiarrhythmic drugs targeting voltage-gated sodium (NaV) channels, specialized protein molecules in the cardiac cell membrane.

Sodium channels serve as gatekeepers regulating the electric activity of cardiac cells. When the electric signals coordinating the heartbeats are not working properly, the heart may experience irregular heartbeats and is considered in an arrhythmic state.

A class of antiarrhythmic drugs works on NaV channels to influence the heart's electrical activity and its beat. Yet, the longstanding failures in drug treatment of heart rhythm disturbances stem mainly from the inability to predict the impact of developed drugs on the activity of NaV and other cardiac ion channels.

"Before our study, there has been no effective preclinical methodology to differentiate useful or potentially harmful drugs at the molecular level," said Vladimir Yarov-Yarovoy, associate professor at the UC Davis Department of Physiology and Membrane Biology.

"To develop and screen novel drugs for treatment of cardiovascular diseases and to minimize their side effects, there is a need to understand the mechanism of antiarrhythmic drug interactions with NaV channels at an atomic scale," he said.

Thanks to several technological breakthroughs and an increasing number of available high-resolution structures of ion channels, such as NaV, researchers are now able to simulate these structures and to modulate the activity of the heart cells by studying their interactions at atomic resolution. The researchers were able to build a model of the human NaV channel based on the closely resembling structure of the electric eel NaV channel using Rosetta computational modeling software.

NaV channels open to allow the sodium ions to flow into the cardiac cells and close within milliseconds. When the drug molecules enter these channels, they bind tightly to the receptor site within the protein preventing the sodium ions from entering the cell and blocking the channel conduction. This change in conduction affects the heart's electric activity and its beat.

In the developed atomic model simulations, two drug molecules are seen transiting into the channel central pore and binding to the receptor site of the protein forming the "hot spots", areas where most favorable drug-protein interaction occur. This binding activity triggers what is known as a high affinity state of the channel.

"High affinity state of the channel is considered the most important state to study drug-protein binding mechanism. Now and for the first time, we can understand how this binding process happens at atomic scale," Yarov-Yarovoy added.

Multi-microsecond simulations of lidocaine (antiarrhythmic and local anesthetic drug) interacting with sodium channels revealed a channel pore access pathway through the intracellular gate and a novel access pathway through a relatively small lateral opening known as fenestration.

Combining molecular modeling software with simulations to study drug-channel interactions is a novel approach that allows future automated virtual drug screening. This technology can be applied to any ion channel and would benefit multiple treatments. Ultimately, this approach advances precision medicine by predicting individual patient responses to drug therapy based on the specific ion channel mutation the patient has.
Co-authors on this study are Colleen Clancy, Phuong Nguyen, Kevin DeMarco and Igor Vorobyov.

This research is supported by the National Institutes of Health (Grant R01GM116961), National Heart, Lung, and Blood Institute (Grant U01HL126273, R01HL128537, R01HL128170, OT2OD026580) and American Heart Association Predoctoral Fellowship (16PRE27260295).

University of California - Davis Health

Related Heart Cells Articles:

Activated T-cells drive post-heart attack heart failure
Chronic inflammation after a heart attack can promote heart failure and death.
Mature heart muscle cells created in the laboratory from stem cells
Generating mature and viable heart muscle cells from human or other animal stem cells has proven difficult for biologists.
A role for mutated blood cells in heart disease?
A new study provides some of the first links between relatively common mutations in the blood cells of elderly humans and atherosclerosis.
A role for mutated blood cells in heart disease?
A new study provides some of the first links between relatively common mutations in the blood cells of elderly humans and atherosclerosis.
Scientists create heart cells better, faster, stronger
Scientists at the Gladstone Institutes identified two chemicals that improve their ability to transform scar tissue in a heart into healthy, beating heart muscle.
Testing stem cells as possible treatment for heart failure
Stem cells are being tested at the Medical University of South Carolina as a possible treatment for heart failure with a preserved ejection fraction, or HFpEF.
Clinical trial to use heart-derived stem cells to restore heart tissue, function
In an article outlining the methodology for an upcoming clinical trial, a multi-center team of researchers discuss the therapeutic potential and logistics of using a cluster of cardiac cells, including stem cells, called 'cardiosphere-derived cells' (CDCs) for myocardial infarction (MI -- commonly referred to as heart attack).
Luminous heart cells: Jellyfish proteins assist in heart rhythm disorder research
Cell models from stem cells serve an ever-increasing role in research of cardiac dysfunction.
Lab-grown nerve cells make heart cells throb
Researchers at Johns Hopkins report that a type of lab-grown human nerve cells can partner with heart muscle cells to stimulate contractions.
Scientists turn skin cells into heart cells and brain cells using drugs
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.

Related Heart Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...